Market concentration
2026-08-10–2026-08-16
The top three brands captured 11.9% of direct mentions in Clinical Trial Management Software.
The comparison uses each group's share of measured direct mentions.
Share of direct mentions
11.9%
88.1%
share of answers
Evidence reviewed · as of Aug 16, 2026